SCCM Resource Library-Anticoagulation During Pediatric ECMO: Evaluation of Efficacy and Cost

Anticoagulation During Pediatric ECMO: Evaluation of Efficacy and Cost

Video Transcription

Video Summary

The speaker discusses the use of systemic anticoagulation during pediatric ECMO (extracorporeal membrane oxygenation) and compares the efficacy and cost-effectiveness of non-fractionated heparin and direct thrombin inhibitors (DTIs) such as bivalirudin. They highlight the variability in institutional practices and the need to reduce bleeding and thrombosis complications. The study, based on a retrospective cohort at their institution, found that DTI use was effective, especially for longer runs, with rapid attainment of therapeutic range and cost effectiveness. They also mention future directions for research, such as assessing transfusion practices and exploring the impact of DTIs on filter life for renal replacement therapy.

Asset Subtitle

Cardiovascular, Procedures, 2023

Asset Caption

Type: star research | Star Research Presentations: Biomarkers I, Pediatrics (SessionID 30007)

Meta Tag

Content Type Presentation

Knowledge Area Cardiovascular

Knowledge Area Procedures

Membership Level Professional

Membership Level Select

Tag Anticoagulation

Tag Extracorporeal Membrane Oxygenation ECMO

Year 2023

Keywords

systemic anticoagulation

pediatric ECMO

direct thrombin inhibitors

bleeding complications

cost effectiveness

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.